Results 201 to 210 of about 103,677 (295)

Development and Validation of RP-HPLC Method for <i>trans</i>-Resveratrol in HPβCD-Loaded Stealth Liposomes: Stability and Release Studies. [PDF]

ACS Omega
Marwa A, Bahtiar A, Shamsuddin AF, Sari K, Syarif M, Restu WK, Jufri M.   +6 more
europepmc   +1 more source

Biomimetic Membrane Interface Technologies for Detection and Isolation of CTCs and EVs: Advances and Opportunities in Liquid Biopsy

Advanced Science, EarlyView.
Biomimetic membrane interface engineering constructs functionalized detection platforms by integrating natural cell membranes, synthetic lipids, or hybrid membranes. This strategy effectively reduces background interference and enables efficient target capture and analysis, showing broad applications in circulating tumor cell separation, extracellular ...
Duo Liu, Jie Yu, Jingxue Li, Yixue Chen, Mengle Peng, Yifan Xu, Yongjun Wu, Lihua Ding, Sitian He   +8 more
wiley   +1 more source

Development of Liposomal Formulations for 1,4-bis-L/L Methionine-Conjugated Mitoxantrone-Amino Acid Conjugates to Improve Pharmacokinetics and Therapeutic Efficacy. [PDF]

Pharmaceutics
Yang TL, Li TK, Chen CT.
europepmc   +1 more source

Pharmacokinetic characterization of tumor influx and efflux of liposomes by rapid removal of circulating liposomes

, 2009
Vincent Fung
openalex   +1 more source

Macrophage–Derived Ferritin Exacerbates Silica‐Induced Pulmonary Fibrosis via PIK3R2‐Mediated Fibroblast Differentiation

Advanced Science, EarlyView.
This study identifies ferritin as a pivotal mediator of silica‐induced pulmonary fibrosis. Macrophage‐derived ferritin drives fibroblast‐to‐myofibroblast differentiation via the PIK3R2/SMAD pathway, while ferritin knockdown alleviates fibrosis. These findings define ferritin as both a biomarker and pathogenic driver, highlighting ferritin‐PIK3R2 ...
Liqun Wang, Xuxi Chen, Hongying Quan, Rui Qian, Shuyu Gong, Qiurong He, Ying Gao, Ajia Axi, Manyu Zhao, Qin Zhang, Ling Zhang, Lijun Peng, Xin Sun, Ben Zhang, Yuqin Yao   +14 more
wiley   +1 more source

Liposome-Based Nanoparticle Delivery Systems for Lung Diseases: Opportunities and Challenges. [PDF]

Int J Nanomedicine
Zhang X, Tu S, Tian J, Liang Y, An Y, Zhang T, Guan H, Xiong B, Qin L, Li Y, Gong L.   +10 more
europepmc   +1 more source

3P-275 Quantitative analysis of interactions between the phospholipid membrane and encapsulated reaction systems in cell-sized liposomes(The 46th Annual Meeting of the Biophysical Society of Japan)

, 2008
Takeshi Sunami, Kazufumi Hosoda, Hiroshi Kita, Norikazu Ichihashi, Tomoaki Matsuura, Hiroaki Suzuki, Tetsuya Yomo   +6 more
openalex   +2 more sources

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Novel Synergistic Strategy for Enhanced Performance in NIR-II FI-PAI-MRI Trimodal Imaging. [PDF]

ACS Omega
Yu H, Zhang Y, Du X, Mou Q.
europepmc   +1 more source

Membrane fusion intermediates between Sendai virus and liposomes

, 2000
Masae Imai, Deshan Zhou, Kazunori Kawasaki   +2 more
openalex   +2 more sources